Rejects Escobio's second attempt to pursue dividend prescription through ordinary proceedings
Dec 3 2020
11th Civil Court
The Eleventh First Instance Civil Court of Guatemala granted Lisa, S.A.'s motion for revocation and nullified the November 6, 2018 resolution that had admitted Escobio, S.A.'s ordinary claim for extinctive prescription of dividends. The court held that a dispute between two commercial entities over dividends decreed in shareholder assemblies must proceed through summary commercial trial, not ordinary proceedings. The claim was rejected, leaving its admission without legal effect.
Escobio, S.A. filed an ordinary claim against Lisa, S.A. seeking a declaration that the obligation to pay dividends had prescribed. The dividends at issue originated from distribution resolutions adopted by the annual general shareholder assembly on November 6, 2006, August 25, 2008, December 16, 2009, April 28, 2010, and April 4, 2011. The court admitted the claim on November 6, 2018, and Lisa filed a motion for revocation against that admission.
This was not Escobio's first attempt to obtain a prescription declaration over the same dividends. Lisa established that on February 22, 2017, Escobio had filed an identical claim before the Fourteenth First Instance Civil Court, where the judge, by resolution of August 3, 2018, had already granted Lisa's motion for revocation and ruled that ordinary proceedings were not the proper route, ordering the dispute be pursued through summary trial.
Lisa argued that revocation was warranted on the following grounds:
The court determined that Escobio's claim sought to declare the prescription of dividend payment obligations arising from shareholder assembly distribution resolutions, a dispute of commercial nature between two corporations. Applying Article 1039 of the Commercial Code, which provides that actions arising from its application shall be pursued through summary trial absent an arbitration agreement, the court concluded that ordinary proceedings were not the proper route.
The court emphasized that the claim arises from the exercise of a corporate right by the plaintiff as shareholder, reinforcing its commercial nature and the mandatory application of summary proceedings.